August 25, 2022 13:00 ET | Source: DelveInsight Business Research LLP DelveInsight Business Research LLP
New York, USA, Aug. 25, 2022 (GLOBE NEWSWIRE) -- New Therapeutics Options in Ischemic Stroke Pipeline as 40+ Key Companies are Working on Drug Profiles | DelveInsight
The prevalence of ischemic stroke has been rising since the past few years, which prompts the growing demand for the treatment options. The market is driven by the high prevalence of ischemic stroke, the increasing prevalence of lifestyle-associated disorders such as diabetes and hypertension. The Companies developing the potential therapies in the last stage of development include Athersys Inc., Acticor Biotech, ZZ Biotech, and several others.
DelveInsight’s 'Ischemic Stroke Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline ischemic stroke therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the ischemic stroke pipeline domain.
Key Takeaways from the Ischemic Stroke Pipeline Report
Request a sample and discover the recent advances in ischemic stroke treatment drugs @ Ischemic Stroke Pipeline Report
The ischemic stroke pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage ischemic stroke drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the ischemic stroke clinical trial landscape.
Ischemic strokes occur when the blood supply to a portion of the brain is cut off. This type of stroke is responsible for the vast majority of all strokes. An ischemic stroke can be caused by a blood clot or by atherosclerosis, a disease that causes the arteries to narrow over time.
A less common ischemic stroke cause is low blood pressure (hypotension), which reduces blood flow to the brain. This is most common in narrowed or diseased arteries. Low blood pressure can be caused by a heart attack, a large blood loss, or a severe infection. The ischemic stroke symptoms vary depending on which part of the brain is affected.
Several tests such as blood, angiography, electrocardiogram, and electrocardiography are used for ischemic stroke diagnosis.
Find out more about ischemic stroke treatment drugs @ Drugs for Ischemic Stroke Treatment
A snapshot of the Ischemic Stroke Pipeline Drugs mentioned in the report:
Learn more about the novel and emerging ischemic stroke pipeline therapies @ Ischemic Stroke Clinical Trials
The ischemic stroke pipeline report proffers an integral view of the ischemic stroke emerging novel therapies segmented by stage, product type, molecule type, mechanism of action, and route of administration.
Scope of the Ischemic Stroke Pipeline Report
Dive deep into rich insights for new drugs for ischemic stroke treatment, visit @ Ischemic Stroke Guidelines
For further information on the ischemic stroke pipeline therapeutics, reach out @ Ischemic Stroke Treatment Drugs
Ischemic Stroke Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key ischemic stroke companies, including Suzhou Yabao Pharmaceutical R&D Co., Ltd., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., among others.
Ischemic Stroke Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical, and forecasted ischemic stroke epidemiology in the 7MM.
Acute Ischemic Stroke Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key acute ischemic stroke companies including Genentech, Pharmazz, GNT Pharma, NoNO, among others.
Acute Ischemic Stroke Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key acute ischemic stroke companies, including Genentech, Pharmazz, GNT Pharma, NoNO, among others.
Acute Ischemic Stroke Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical, and forecasted acute ischemic stroke epidemiology in the 7MM.
Persistent Depressive Disorder Market | Gene Therapy for Ocular Rare Disease Market | Congestive Heart Failure Market | CRISPR Therapies Pipeline | Desmoplastic Small Round Cell Tumors Market | India Healthcare Outlook Report | Psychosis Market | Dental Lasers Market | Primary Immune Deficiency Market I Dyslipidemia Market | Lateral Epicondylitis Disease Market | Castration-Resistant Prostate Cancer Market | Metrorrhagia Market | Global Messenger RNA-based Vaccines and Therapeutics Market | Negative Pressure Wound Therapy Systems Market | US Healthcare Outlook Report | Mucinous Cystic Neoplasms Market | Hot Flashes Market | Varicose Veins - Market | Hemostats Market | Injectable Drug Delivery Devices Market | Breast Pumps Market | Physiotherapy Equipment Market | Trastuzumab Biosimilars Insight | Deep Brain Stimulation Devices Market | Retinoblastoma Market | Venous Stenosis Market | Tumor Ablation Market | Substance Abuse Market | Insulin Glargine Biosimilar Insight | Interspinous Spacers Market | Anti-hypertension Market
Key Companies in the Cardiology Segment
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
Connect with us at LinkedIn